Topics:
Acute Coronary Syndromes (ACS)
Current versions available to download
Current translated versions available to download:
Authors
William Wijns (Chairperson), Philippe Kolh (Chairperson), Nicolas Danchin, Carlo Di Mario, Volkmar Falk, Thierry Folliguet, Scot Garg, Kurt Hubert, Stefan James, Juhani Knuuti, Jose Lopez-Sendon, Jean Marco, Lorenzo Menicanti, Miodrag Ostojic, Massimo F. Piepoli, Charles Pirlet, Jose L. Pomar, Nicolaus Reifart, Flavio L. Ribichini, Martin J. Schalij, Paul Sergeant, Patrick W. Serruys,Sigmund Silber, Miguel Sousa Uva, David Taggart
Endorsed by:
Table of contents: Full Text (ESC Clinical Practice Guidelines)
|
|
|
Introduction and definitions
|
- Method of review
- Definition of levels of recommendation
|
Indications for PCI
|
- Indications for PCI in stable coronary artery disease
- Indications for PCI in acute coronary syndromes without ST-segment elevation
- Indications for PCI in ACS with ST-segment elevation
|
Adjunctive medications for PCI
|
- Acetylsalicylic acid
- Ticlopidine and clopidogrel
- Unfractionated heparin
- Low molecular weight heparins
- Glycoprotein IIb/IIIa inhibitors
- Direct thrombin inhibitors
|
Adjunctive devices for PCI
|
- Intracoronary brachytherapy for in-stent restenosis
- Cutting balloon
- Rotablation
- Directional coronary atherectomy
- Embolic protection devices
- Adjunctive diagnostic technology
|
Drug-eluting stents
|
- Vessel size, long lesions, diabetes,
- Stent thrombosis of DES
- Indications for DES
|
Previous versions
Previous versions
Percutaneous coronary interventions
European Heart Journal 2005;26:804-847 - Full Text
Educational Slide-set 2005
A complete list of ESC Clinical Practice Guidelines (current and previous versions) endorsed by ESC National Society Members is available here